Cresset Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-300
Closed -$156K – 1854
2024
Q4
$156K Sell
300
-400
-57% -$220K ﹤0.01% 1594
2024
Q3
$433K Sell
700
-2,300
-77% -$1.36M ﹤0.01% 1611
2024
Q2
$1.66M Buy
+3,000
New +$1.72M 0.01% 813

Other funds holding TMO

Cresset Asset Management's TMO Position: Q2 2026 in Review

Cresset Asset Management increased its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, buying an estimated $2.23M and bringing the position to 48,390 shares worth $24.3M. The position accounts for 0.09% of the portfolio, ranked #147.

Cresset Asset Management first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $36.3M in Q3 2024. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cresset Asset Management held 48,390 shares of Thermo Fisher Scientific worth $24.3M as of Q2 2026.
  • Cresset Asset Management bought 4,642 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.23M.
  • Thermo Fisher Scientific made up 0.09% of Cresset Asset Management's portfolio in Q2 2026, its #147 holding.
  • Cresset Asset Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
  • Cresset Asset Management's Thermo Fisher Scientific position peaked at $36.3M in Q3 2024.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.